All News

A new challenge to Obamacare has even its most ardent supporters nervous.

In this installment in a series on privacy and information security concerns, I will discuss steps you can take to safeguard your patients’ personal information.

A smartphone app for pelvic floor muscle training has valuable potential as a portal to patient care and education and for facilitating clinical outcomes research, according to its developers from the University of California, San Francisco.

Novel ultrasound-based techniques for propelling and breaking kidney stones could soon join ESWL and URS in the urologist’s treatment armamentarium. In this interview, Michael Bailey, PhD, discusses how these technologies work, what they’re capable of, and where they are in development.

Urologists lament how prior authorization and EHRs take them away from their patients.

Proposed cuts by the Centers for Medicare & Medicaid Services in Medicare payments for radiation oncology services would force an estimated 30% of community-based radiation therapy centers to close their doors, according to a statement sent to CMS by the American Society of Radiation Oncology.

A robot-assisted abdominal approach to pelvic organ prolapse repair has a favorable safety profile and is associated with durable anatomic outcomes, findings of a retrospective chart review indicate.

Other products highlighted in this slideshow include a trial system for incontinence therapy, a compact catheter, a wearable digital technology solution for continence care assessment and management, and laser fiber and sheath system.

As we approach the end of the year, the tax moves that you make-or don’t make-can have a significant impact on your 2015 tax return.

A prostate cancer vaccine and an infertility diagnostic tool are among the other pipeline products discussed in this round-up.

The pressure is on for many U.S. urologists to take a hard look at whether to practice privately or as part of a hospital system. We asked two urologists to weigh in about the lessons they learned in transitioning from one practice type to another.

The time has arrived for all urologists to become involved in the business side of their practice.

OnabotulinumtoxinA (Botox) appears to offer long-term benefits in patients with neurogenic detrusor overactivity, recent study results indicate.

Intravesical onabotulinumtoxinA (Botox) reduces bladder pain in patients with interstitial cystitis/bladder pain syndrome (IC/BPS), two separate studies show.

Symptomatic urinary tract infection is unlikely after office-based cystoscopy, although recent antibiotic exposure or hospitalization raise infection risk, according to a recent study.

An initial assessment of robotic ureteral reconstruction using buccal mucosa graft indicates that it is a feasible and reproducible approach for reconstruction of complex ureteral strictures, reconstructive urologists reported at the AUA annual meeting in New Orleans.

Don't count out men who have not recovered urinary and erectile function at 12 months after radical prostatectomy.

A recent study evaluated electrical stimulation of the afferent nerves in the foot as a way of decreasing symptoms of overactive bladder.

Researchers recently presented 12-month follow-up data from a prospective, multicenter trial of a device for sacral neuromodulation.

In other personnel news, Thomas Jefferson’s Sidney Kimmel Cancer Center has a new director and LUGPA has its first CEO.

This slideshow presents a case study of a 30-year-old male with discomfort in left groin region due to mass/swelling for 1 year.

The Sonablate 450, SonaCare Medical’s high-intensity focused ultrasound (HIFU) device, has received FDA clearance for prostate tissue ablation.

Exclusive data from our State of the Specialty survey reveals the growing importance of non-physician providers in the urology work force.

Work-related risks for bladder cancer are on the rise, but the occupations putting workers at risk seem to be evolving, according to a meta-analysis published online in JAMA Oncology (Oct. 8, 2015).

Urology Times State of the Specialty Survey 2015

Study findings point to “a concept that has haunted clinical trialists for years,” says one expert.

An immune checkpoint inhibitor provides “a real opportunity to change clinical practice” for patients with metastatic renal cell carcinoma, a study author says.

New study findings from the Ronald Reagan UCLA Medical Center, Los Angeles add evidence supporting the potential for targeted magnetic resonance-ultrasound (MR-US) fusion biopsy to improve the diagnosis of prostate cancer. Learn more